109 related articles for article (PubMed ID: 17264770)
21. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
[TBL] [Abstract][Full Text] [Related]
22. The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells.
Olsnes AM; Ersvaer E; Ryningen A; Paulsen K; Hampson P; Lord JM; Gjertsen BT; Kristoffersen EK; Bruserud Ø
Br J Haematol; 2009 Jun; 145(6):761-74. PubMed ID: 19388934
[TBL] [Abstract][Full Text] [Related]
23. IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
Le TT; Skak K; Schroder K; Schroder WA; Boyle GM; Pierce CJ; Suhrbier A
PLoS One; 2016; 11(4):e0153975. PubMed ID: 27100888
[TBL] [Abstract][Full Text] [Related]
24. RasGRPs are targets of the anti-cancer agent ingenol-3-angelate.
Song X; Lopez-Campistrous A; Sun L; Dower NA; Kedei N; Yang J; Kelsey JS; Lewin NE; Esch TE; Blumberg PM; Stone JC
PLoS One; 2013; 8(8):e72331. PubMed ID: 23991094
[TBL] [Abstract][Full Text] [Related]
25. A new cytotoxic casbane diterpene from Euphorbia pekinensis.
Liang QL; Dai CC; Jiang JH; Tang YP; Duan JA
Fitoterapia; 2009 Dec; 80(8):514-6. PubMed ID: 19560525
[TBL] [Abstract][Full Text] [Related]
26. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
[TBL] [Abstract][Full Text] [Related]
27. New therapeutic options for actinic keratosis and basal cell carcinoma.
Sligh JE
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
[TBL] [Abstract][Full Text] [Related]
28. Four new diterpenoids from the roots of Euphorbia fischeriana.
Wang HB; Chen W; Zhang YY; Wang XY; Liu LP; Tong LJ; Chen Y
Fitoterapia; 2013 Dec; 91():211-216. PubMed ID: 24042072
[TBL] [Abstract][Full Text] [Related]
29. [Taxotere in various solid tumors].
Orel NF
Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
[No Abstract] [Full Text] [Related]
30. Quantitative Analysis of Ingenol in Euphorbia species via Validated Isotope Dilution Ultra-high Performance Liquid Chromatography Tandem Mass Spectrometry.
Béres T; Dragull K; Pospíšil J; Tarkowská D; Dančák M; Bíba O; Tarkowski P; Doležal K; Strnad M
Phytochem Anal; 2018 Jan; 29(1):23-29. PubMed ID: 28786149
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
[TBL] [Abstract][Full Text] [Related]
32. Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Sullivan TJ
Curr Opin Ophthalmol; 2012 Sep; 23(5):439-42. PubMed ID: 22828167
[TBL] [Abstract][Full Text] [Related]
33. Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.
Cozzi SJ; Ogbourne SM; James C; Rebel HG; de Gruijl FR; Ferguson B; Gardner J; Lee TT; Larcher T; Suhrbier A
J Invest Dermatol; 2012 Apr; 132(4):1263-71. PubMed ID: 22189786
[TBL] [Abstract][Full Text] [Related]
34. Antiproliferative activity of the diterpenes jatrophone and jatropholone and their derivatives.
Theoduloz C; Rodríguez JA; Pertino M; Schmeda-Hirschmann G
Planta Med; 2009 Nov; 75(14):1520-2. PubMed ID: 19562659
[TBL] [Abstract][Full Text] [Related]
35. Daphnane-type diterpene esters as powerful agents for the treatment of leukemia.
Yazdanparast R; Moosavi MA
Med Hypotheses; 2006; 67(6):1472-3. PubMed ID: 16934949
[No Abstract] [Full Text] [Related]
36. A new cytotoxic cembrane diterpene from the roots of Euphorbia pekinensis Rupr.
Hou P; Zeng Y; Ma B; Bi K; Chen X
Fitoterapia; 2013 Oct; 90():10-3. PubMed ID: 23850541
[TBL] [Abstract][Full Text] [Related]
37. Acute kerato-uveitis associated with topical self-administration of the sap of the Petty Spurge (Euphorbia peplus).
Eke T
Eye (Lond); 1994; 8 ( Pt 6)():694-6. PubMed ID: 7867832
[No Abstract] [Full Text] [Related]
38. Euphorbia peplus: 18th-century insights on a 21st-century therapy.
Nambudiri NS; Nambudiri VE
JAMA Dermatol; 2013 Sep; 149(9):1081. PubMed ID: 24048430
[No Abstract] [Full Text] [Related]
39. The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate.
Ogbourne SM; Parsons PG
Fitoterapia; 2014 Oct; 98():36-44. PubMed ID: 25016953
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of ERK1/2 activation determine sensitivity of acute myeloid leukaemia cells to the induction of apoptosis by the novel small molecule ingenol 3-angelate (PEP005).
Hampson P; Wang K; Milverton L; Ersvaer E; Bruserud O; Lord JM
Apoptosis; 2010 Aug; 15(8):946-55. PubMed ID: 20467815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
